FLOT Plus Durvalumab Leads to High pCR Rate in Gastric Cancer
Durvalumab + 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a higher pathological complete response (pCR) rate than FLOT alone.
Read More
Author: Teresa Sellinger
Switching from IV to Subcutaneous Vedolizumab Deemed Safe & Effective
Study results indicate that switching from intravenous to subcutaneous vedolizumab in patients with IBD appears to be safe and effective.
Read More
The Tardive Dyskinesia Impact Scale Provides a Holistic Evaluation for Physicians
The Tardive Dyskinesia Impact Scale complements the Abnormal Involuntary Movement Scale by combining clinician-rated and patient-reported perspectives.
Read More
Unveiling the Culinary Connection: How Diet Shapes the Landscape of IBD
Several studies were presented at the 2024 Crohn’s & Colitis Congress, covering the impacts on IBD of malnutrition, dietary supplements, and various diets.
Read More
Physicians Running for Office
Although many don’t think politics has a place in the exam room, political policies impact healthcare—leading some physicians to consider joining the fray.
Read More
Study Identifies “Significant Lack of Information” on HRQOL Measures in Psoriasis
Patient-reported outcomes on HRQOL in psoriasis are limited and require additional validation to properly assess individuals with the condition.
Read More
Patients With Acute Myeloid Leukemia & TP53 Mutation Have Lower Overall Survival, Complete Remission
Research from ASH 2023 showed standard treatment options lack efficacy for patients who are positive for the TP53 mutation with AML.
Read More
Think You Know the Latest from AAO on Retinal Vascular Disease?
A quiz based on the latest retinal vascular disease research, news and studies from AAO.
Read More
Psoriasis Tied to Atherosclerosis
At Maui Derm Hawaii, Joel Gelfand, MD, MSCE, presented as part of “Challenging Cases in Psoriasis.” He published 2 related papers recently, which we summarize.
Read More
Meaningful Disease Burden Measurements in Patients With Psoriasis
Bruce Strober, MD, PhD, published a paper recently in JAMA Dermatol focusing on disease burden measurements of meaning to patients with psoriasis.
Read More
IL-23 p19 Inhibitors Safe for Moderate-to-Severe Plaque Psoriasis
At Maui Derm Hawaii, Andrew Blauvelt, MD, MBA, presented as part of “Psoriasis Update: 2024.” Here, we summarize a paper he published in this area of study.
Read More
Psoriatic Disease Management Suboptimal
At Maui Derm Hawaii, held January 22-26, 2024, Linda Stein-Gold, MD, presented as part of “Challenging Cases in Psoriasis.”
Read More
Catching People Doing the Right Thing: The Overlooked Art of Positive Feedback
We can be so focused on what has gone wrong with a project, system, or endeavor that we forget to see what is going right.
Read More
Medical Fiction: The Gatekeeper of Life
In this medical fiction, Max wields his stamp with zeal, evaluating prior authorizations by cost rather than quality, as Silvia’s symptoms force her to navigate the same greedy system.
Read More
Examining Disparities in the Management of NSCLC
2023 NACLC Opening Keynote Speaker Marjory Charlot, MD, MPH, MSc, presented “Equities and Disparities,” focusing on disparities in the management of NSCLC.
Read More
Social Determinants of Health Influence Survival in NSCLC
Social determinants of health influenced the achievement of textbook oncological outcomes and overall survival in non-small cell lung cancer.
Read More
Lymphovascular Invasion May Be a Key Predictor for Postoperative Recurrence of NSCLC
Lymphovascular invasion is an independent predictor for shorter recurrence-free survival for patients with stage I NSCLC.
Read More
Q&A: The Need to Evaluate & Manage Insomnia in Patients With Alzheimer’s Disease
Research finds a significant association between diagnosed insomnia and increased prevalence of behavioral symptoms in patients with Alzheimer’s Disease.
Read More
How Struggling Hospital Operating Margins & Rising Patient Volume Affect Physicians
Although patient volume is rising in healthcare systems, costs that outpace gains up to 3:1 continue to squeeze margins.
Read More
Improved Histiocytic Neoplasm Treatments & Life Expectancy Bring QOL Challenges
Thanks to new treatments, more people survive histiocytic neoplasms, but their survival comes with challenges, according to findings published in Blood.
Read More